in combination with a steroid taper regimen in adults with giant cell arteritis (GCA). The multicentre, randomised, double-blind, placebo-controlled trial enrolled 428 patients. Divided into two ...

EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis: North Chicago, Illinois Monday, March 3, 2025, 15:00 Hrs [IST] AbbVie annou ...

double-blind placebo-controlled study designed to evaluate the safety and efficacy of upadacitinib in 428 patients with GCA. The study consists of two periods. The first period, which is reported ...